Searched for
YL BIOLOGICS
The bitterness of sugarIndia's alarming sugar consumption in 2022 led to a diabetes epidemic. Managing heart disease risks through weight loss, exercise, and pers...- Biocon puts arthritis drug on backburnerBiocon and Mylan have been working for a decade on a biosimilar version of the drug, originally sold by Amgen under brand name Enbrel.
- Lupin, Nichi-Iko tie up for commercialization of biosimilar Etanercept in JapanMumbai based Lupin pharma and Japan's Nichi-Iko have tied up for the distribution, promotion and sale of Lupin’s recently-filed biosimilar ...
- Lupin's JV completes global trials for RA biosimilarThe randomised trial of 52 weeks was conducted in 11 countries and included over 500 patients, Lupin said.
- Top stocks in focus on 09 February 2018Here is a list of top stocks that are likely to take focus in today's trading session.
- Top stocks in focus on 08 February 2018Take a look at top stocks that are likely to stay in limelight in today's trading.
- Lupin forms Joint Venture with Japan's Yoshindo IncLupin's Etanercept biosimilar, developed by its Biotechnology Research Group in Pune will be the first product to be licensed for clinical ...
Load More